Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2INDUSTRY 2NETWORK 1

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Head & Neck 1Classical hematology 1Breast 1

Conditions

Breast Neoplasms 7244Neoplasms 4539Prostatic Neoplasms 3489Colorectal Neoplasms 2940Carcinoma, Non-Small-Cell Lung 2831Lung Neoplasms 2547Leukemia, Myeloid, Acute 1982Pancreatic Neoplasms 1874Multiple Myeloma 1811Carcinoma, Hepatocellular 1733Neoplasm Metastasis 1585Stomach Neoplasms 1502Lymphoma 1457Precursor Cell Lymphoblastic Leukemia-Lymphoma 1435Head and Neck Neoplasms 1435Brain Neoplasms 1373Melanoma 1348Ovarian Neoplasms 1342Leukemia 1303Rectal Neoplasms 1270Recurrence 1255Colonic Neoplasms 1204Glioblastoma 1138Uterine Cervical Neoplasms 1096Lymphoma, Non-Hodgkin 1066Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 965Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 932Squamous Cell Carcinoma of Head and Neck 921

Interventions

Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Interventional × Glaucoma × Clear all
NCT01997255 2016-05-05

Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)

Baylor College of Medicine

Phase 2 Withdrawn

Epilepsy, Glaucoma, Sturge-Weber Syndrome, Port-Wine Stain

NCT01105923 2015-02-02

MAPLE

Brigham and Women's Hospital

Phase NA Unknown
140 enrolled
BreastClassical hematologyHead & Neck

Anemia, Sickle Cell, Asthma, Attention Deficit Disorder with Hyperactivity, Bone Diseases, Metabolic, Breast Neoplasms, Coronary Artery Disease, Diabetes Mellitus, Glaucoma, Heart Failure, Hemophilia A, Hypertension, Hyperthyroidism, Hypothyroidism, Myasthenia Gravis, Osteoporosis, Stroke, Pulmonary Disease, Chronic Obstructive, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡